The Biology of NBCe1 in Health and Disease

NBCe1 在健康和疾病中的生物学

基本信息

  • 批准号:
    9896804
  • 负责人:
  • 金额:
    $ 60.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-03-19 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY SLC4 proteins in the kidney play an essential role in mediating the coupled transport (symporters, exchangers) of Na+, HCO3⎯, CO32⎯, and Cl⎯ in the proximal tubule and collecting duct. Infants and children with mutations in the electrogenic Na+-CO32⎯ symporter NBCe1 and the Cl⎯/HCO3⎯ exchanger AE1 develop severe proximal and distal renal tubular acidosis respectively. How disease causing mutations impair their transport mechanisms at the molecular level is unknown. Towards this goal, we have recently solved by cryoelectron microscopy (cryoEM) the outward facing structure of NBCe1, the inward and outward facing structures of AE1, and have obtained 2D class averages of the Na+-CO32⎯/Cl⎯ exchanger NDCBE representing major advances in the field. These significant advances coupled with our preliminary functional mutagenesis and Molecular Dynamics computational analyses make it possible for the first time in the transport field to achieve the long-term objective of understanding the detailed structure-functional properties of SLC4 transporters and their impairment by disease causing mutations. To accomplish this objective, the project addresses the following specific aims: Aim 1: Structural Determinants of the AE1, NBCe1, and NDCBE Ion Coordination Sites, Transport Modes and Ion Specificities: In this aim, using cryoEM, functional mutagenesis and Molecular Dynamics computational analyses, the hypothesis that the ion coordination sites in these transporters encode both their respective transport modes and unique ion transport specificities will be examined. Aim 2: Characterize the Structural Components of AE1, NBCe1 and NDCBE Permeation Pores, Ion Selectivity and Energetics: In this aim, using cryoEM, functional mutagenesis and Molecular Dynamics computational analyses, the hypothesis that differences in the structure and energetics of ion permeation among these transporters plays an important role in determining the selectivity of ions reaching their coordination sites in both outward and inward facing conformations will be examined. Aim 3: Transport Models for AE1, NBCe1 and NDCBE, and Characterization of the Transport Abnormalities Induced by Renal Tubular Acidosis Causing Mutations: The dynamic transport models of AE1, NBCe1 and NDCBE will be generated based on preliminary data, and the results obtained in Aims 1 and 2. How disease causing mutations impair these mechanistic transporter molecular models will be determined. This proposal represents a significant contribution to Nephrology and Medicine given the importance of SLC4 transporters in regulating kidney ion balance, systemic acid-base chemistry, blood pressure, and the maintenance of cell function and growth.
项目摘要 肾脏中的SLC 4蛋白在介导偶联转运(共转运体, 近端小管和集合管中Na+、HCO 3+、CO 32+和Cl+的交换器)。婴儿和儿童 随着产电Na+-CO 32 β同向转运体NBCe 1和Cl β/HCO 3 β交换体AE 1的突变, 严重的近端和远端肾小管酸中毒。致病突变如何损害他们的 分子水平上的运输机制是未知的。为了实现这一目标,我们最近解决了 冷冻电子显微镜(cryoEM):NBCe 1的外向结构,NBCe 1的内向和外向结构。 AE 1的结构,并获得了Na+-CO_32 ~+/Cl ~-交换剂NDCBE的二维类平均值 代表了该领域的重大进展。这些重大进展加上我们初步的功能性 诱变和分子动力学计算分析使其有可能在第一次 运输领域,以实现了解详细的结构功能的长期目标 SLC 4转运蛋白的性质及其因致病突变而受到的损害。为了实现这一 目标1:AE 1的结构决定因素, NBCe 1和NDCBE离子配位位点、传输模式和离子特异性: cryoEM、功能诱变和分子动力学计算分析, 这些转运蛋白中的离子配位位点编码它们各自的转运模式和独特的离子配位位点。 将审查运输的具体情况。目的2:表征AE 1、NBCe 1和 NDCBE渗透孔、离子选择性和能量学:为此,使用cryoEM、功能诱变 和分子动力学计算分析,假设在结构和 离子在这些转运体之间的渗透能在决定选择性方面起着重要作用 将检查离子到达它们的配位位点的外向和内向构象。 目的3:AE 1、NBCe 1和NDCBE的传输模型,以及传输异常的表征 肾小管酸中毒诱发突变:AE 1、NBCe 1和 将根据初步数据和目标1和目标2中获得的结果生成NDCBE。如何疾病 将确定导致突变损害这些机械转运蛋白分子模型的因素。这项建议 鉴于SLC 4转运蛋白的重要性,代表了对肾脏病学和医学的重大贡献 在调节肾离子平衡、全身酸碱化学、血压和维持细胞 功能和成长。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IRA KURTZ其他文献

IRA KURTZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IRA KURTZ', 18)}}的其他基金

The Biology of NBCe1 in Health and Disease
NBCe1 在健康和疾病中的生物学
  • 批准号:
    10379238
  • 财政年份:
    2019
  • 资助金额:
    $ 60.09万
  • 项目类别:
The Biology of NBCe1 in Health and Disease
NBCe1 在健康和疾病中的生物学
  • 批准号:
    10609427
  • 财政年份:
    2019
  • 资助金额:
    $ 60.09万
  • 项目类别:
NBC1 and Proximal RTA: Pathogenesis and Treatment
NBC1 和近端 RTA:发病机制和治疗
  • 批准号:
    7979306
  • 财政年份:
    2009
  • 资助金额:
    $ 60.09万
  • 项目类别:
The Biology of NBCe1 in Health and Disease
NBCe1 在健康和疾病中的生物学
  • 批准号:
    8779719
  • 财政年份:
    2007
  • 资助金额:
    $ 60.09万
  • 项目类别:
NBC1 and Proximal RTA: Pathogenesis and Treatment
NBC1 和近端 RTA:发病机制和治疗
  • 批准号:
    8063639
  • 财政年份:
    2007
  • 资助金额:
    $ 60.09万
  • 项目类别:
The Biology of NBCe1 in Health and Disease
NBCe1 在健康和疾病中的生物学
  • 批准号:
    8597417
  • 财政年份:
    2007
  • 资助金额:
    $ 60.09万
  • 项目类别:
NBC1 and Proximal RTA: Pathogenesis and Treatment
NBC1 和近端 RTA:发病机制和治疗
  • 批准号:
    7316517
  • 财政年份:
    2007
  • 资助金额:
    $ 60.09万
  • 项目类别:
NBC1 and Proximal RTA: Pathogenesis and Treatment
NBC1 和近端 RTA:发病机制和治疗
  • 批准号:
    7617101
  • 财政年份:
    2007
  • 资助金额:
    $ 60.09万
  • 项目类别:
The Biology of NBCe1 in Health and Disease
NBCe1 在健康和疾病中的生物学
  • 批准号:
    8435734
  • 财政年份:
    2007
  • 资助金额:
    $ 60.09万
  • 项目类别:
Modulation of Electrogenic Sodium Bicarbonate Transport
电化学碳酸氢钠传输的调节
  • 批准号:
    6833958
  • 财政年份:
    2003
  • 资助金额:
    $ 60.09万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 60.09万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 60.09万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.09万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.09万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 60.09万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.09万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 60.09万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 60.09万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 60.09万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.09万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了